Infección por SARS-CoV-2 y miocarditis

Palabras clave: COVID-19, SARS-CoV-2, miocardio, miocarditis, ecocardiografía transtorácica, biopsia.

Resumen

COVID-19 es una enfermedad infecciosa respiratoria aguda, causada por el SARS-CoV-2, un nuevo coronavirus, que se extendió rápidamente por todo el mundo, dando como resultado una pandemia. Los pacientes presentan un amplio espectro de manifestaciones clínicas, entre ellas, la miocarditis, y de manera alterna, algunos pacientes sin síntomas de enfermedad cardíaca, tienen anomalías en las pruebas, como elevación de la troponina y arritmias cardíacas en el electrocardiograma, o anomalías en las imágenes cardíacas. La patogenia del compromiso miocárdico no es clara, pero las dos principales teorías prevén un papel directo de la enzima convertidora de angiotensina 2, que funciona como el receptor viral, y una respuesta hiperinmune, que también puede conducir a una presentación aislada. El estándar de oro del diagnóstico es la biopsia endomiocárdica, la cual no está disponible en la mayoría de los escenarios. En esta revisión, se pretende brindar al lector pautas para identificar las manifestaciones clínicas, ayudas diagnósticas y manejo de los pacientes con sospecha de miocarditis por COVID-19.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Santiago Forero-Saldarriaga, Clínica Universitaria Colombia, Fundación Universitaria San Martín

Médico, Residente de Medicina Interna, Fundación Universitaria Sanitas, Clínica Universitaria Colombia. Grupo de Enfermedades Infecciosas y Crónicas (GEINCRO), Fundación Universitaria San Martín. Bogotá D.C., Colombia. https://orcid.org/0000-0002-3545-7452.

José David Puerta-Rojas, Fundación Universitaria Sanitas

Médico, Residente de Medicina Interna, Fundación Universitaria Sanitas. Bogotá D.C., Colombia.
https://orcid.org/0000-0001-8570-6544.

Ruth Nathaly Estupiñán-Paredes, Clínica Universitaria Colombia

Médica General, Clínica Universitaria Colombia. Bogotá D.C., Colombia.
https://orcid.org/0000-0002-8498-550X.

Luis Carlos Coy-Pedraza, Fundación Universitaria Sanitas

Médico General, Fundación Universitaria Sanitas. Bogotá D.C., Colombia.

Nelson Leandro Moreno-Ruiz, Clínica Universitaria Colombia

Médico, Especialista en Medicina Interna, Especialista en Epidemiología y Cardiología, Clínica Universitaria Colombia. Bogotá D.C., Colombia. https://orcid.org/0000-0002-0489-0106.

Jeffrey Castellanos-Parada, Clínica Universitaria Colombia

Médico, Especialista en Medicina Interna, Especialista en Cardiología, Clínica Universitaria Colombia. Bogotá D.C., Colombia. https://orcid.org/0000-0001-5325-0538.

Referencias bibliográficas

Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020;17:1463-1471. https://doi.org/10.1016/j.hrthm.2020.05.001.

Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, et al. Systematic review of COVID-19 related myocarditis: Insights on management and outcome. Cardiovasc Revasc Med 2021;23:107-113. https://doi.org/10.1016/j.carrev.2020.08.028.

Caballeros-Lam M, de la Fuente-Villena A, Hernández-Hernández A, García-de Yébenes M, Bastarrika-Alemañ G. Cardiac magnetic resonance characterization of COVID-19 myocarditis. Rev Esp Cardiol 2020;73:863-864. https://doi.org/10.1016/j.rec.2020.06.018.

Kariyanna PT, Sutarjono B, Grewal E, Singh KP, Aurora L, Smith L, et al. A systematic review of COVID-19 and myocarditis. Am J Med Case Rep 2020;8:299-305.

Agdamag ACC, Edmiston JB, Charpentier V, Chowdhury M, Fraser M, Maharaj VR, et al. Update on COVID-19 myocarditis. Medicina (Kaunas) 2020;56:678. https://doi.org/10.3390/medicina56120678.

Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, et al. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart 2020;106:1127-1131. https://doi.org/10.1136/heartjnl-2020-317186.

Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol 2020;311:116-121. https://doi.org/10.1016/j.ijcard.2020.03.087.

Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020;76:533-546. https://doi.org/10.1016/j.jacc.2020.06.007.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3.

Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging 2020;13:2330-2339. https://doi.org/10.1016/j.jcmg.2020.05.004.

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265-1273. https://doi.org/10.1001/jamacardio.2020.3557.

Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2021;6:116-118. https://doi.org/10.1001/jamacardio.2020.4916.

Ozieranski K, Tyminska A, Jonik S, Marcolongo R, Baritussio A, Grabowski M, et al. Clinically suspected myocarditis in the course of severe acute respiratory syndrome novel coronavirus-2 infection: Fact or fiction? J Card Fail 2021;27:92-96. https://doi.org/10.1016/j.cardfail.2020.11.002.

Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J 2020;41:1861-1862. https://doi.org/10.1093/eurheartj/ehaa286.

Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 2020;45:230-232. https://doi.org/10.1007/s00059-020-04909-z.

Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020;22:911-915. https://doi.org/10.1002/ejhf.1828.

Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol 2021;77:314-325. https://doi.org/10.1016/j.jacc.2020.11.031.

Manfredonia I, Incarnato D. Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies. Biochem Soc Trans 2021;49:341-352. https://doi.org/10.1042/bst20200670.

Centros para el Control y Prevención de Enfermedades (CDC), Departamento de Salud y Servicios Humanos. Hoja informativa. Información básica sobre el SRAS. Atlanta, Estados Unidos: CDC; 2004. Acceso 2021 de 9 de noviembre. Disponible en https://www.cdc.gov/sars/about/fs-SARS-sp.pdf.

Celly-Trujillo AI, Villamil-Jiménez LC. Estudio retrospectivo del nuevo coronavirus MERS-COV 2012-2013. Rev Lasallista Investig 2014;11:71-77.

Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart 2020;106:1132-1141. https://doi.org/10.1136/heartjnl-2020-317056.

Cheng R, Leedy D. COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart 2020;106:1122-1124. https://doi.org/10.1136/heartjnl-2020-317025.

Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and myocarditis: What do we know so far? CJC Open 2020;2:278-285. https://doi.org/10.1016/j.cjco.2020.05.005.

Rashid S, Gul U, Ali M, Sadiq T, Kiyani AM. Coronary artery ectasia: Clinical and angiographic features. J Coll Physicians Surg Pak 2018;28:824-828. https://doi.org/10.29271/jcpsp.2018.11.824.

Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020;92:577-583. https://doi.org/10.1002/jmv.25757.

Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636-2648. https://doi.org/10.1093/eurheartj/eht210.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620-2629. https://doi.org/10.1172/jci137244.

Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail 2011;13:398-405. https://doi.org/10.1093/eurjhf/hfq229.

He J, Wu B, Chen Y, Tang J, Liu Q, Zhou S, et al. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol 2020;36:961-966. https://doi.org/10.1016/j.cjca.2020.03.028.

McCullough SA, Goyal P, Krishnan U, Choi JJ, Safford MM, Okin PM. Electrocardiographic findings in coronavirus disease-19: Insights on mortality and underlying myocardial processes. J Card Fail 2020;26:626-632. https://doi.org/10.1016/j.cardfail.2020.06.005.

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018;72:2231-2264. https://doi.org/10.1016/j.jacc.2018.08.1038.

Sandoval Y, Januzzi JL, Jr., Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol 2020;76:1244-1258. https://doi.org/10.1016/j.jacc.2020.06.068.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-810. https://doi.org/10.1001/jamacardio.2020.0950.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-818. https://doi.org/10.1001/jamacardio.2020.1017.

Figliozzi S, Masci PG, Ahmadi N, Tondi L, Koutli E, Aimo A, et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest 2020;50:e13362. https://doi.org/10.1111/eci.13362.

Nie SF, Yu M, Xie T, Yang F, Wang HB, Wang ZH, et al. Cardiac troponin I is an independent predictor for mortality in hospitalized patients with COVID-19. Circulation 2020;142:608-610. https://doi.org/10.1161/circulationaha.120.048789.

Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020;8:518-526. https://doi.org/10.1016/S2213-2600(20)30121-1.

Rivara MB, Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients. PLoS One 2012;7:e40515. https://doi.org/10.1371/journal.pone.0040515.

Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging 2020;21:949-958. https://doi.org/10.1093/ehjci/jeaa178.

Canadian Society of Echocardiography (CSE). Practice of echocardiography during the COVID 19 pandemic: Guidance from the Canadian Society of Echocardiography. Canada: CSE; 2020. Acceso 5 de noviembre de 2021. Disponible en https://csecho.ca/2020/03/30/practice-of-echocardiography-during-the-covid-19-pandemic-guidance-from-the-canadian-society-of-echocardiography/.

Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J Am Coll Cardiol 2009;53:1475-1487. https://doi.org/10.1016/j.jacc.2009.02.007.

Peretto G, Sala S, Caforio ALP. Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement. Eur Heart J 2020;41:2124-2125. https://doi.org/10.1093/eurheartj/ehaa396.

Ojha V, Verma M, Pandey NN, Mani A, Malhi AS, Kumar S, et al. Cardiac magnetic resonance imaging in coronavirus disease 2019 (COVID-19): A systematic review of cardiac magnetic resonance imaging findings in 199 patients. J Thorac Imaging 2021;36:73-83. https://doi.org/10.1097/rti.0000000000000574.

Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.

Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med 2021;16:1123-1129. https://doi.org/10.1007/s11739-021-02635-w.

Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial management of fulminant myocarditis: A scientific statement from the American Heart Association. Circulation 2020;141:e69-92. https://doi.org/10.1161/cir.0000000000000745.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-1034. https://doi.org/10.1016/s0140-6736(20)30628-0.

Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 2020;48:773-777. https://doi.org/10.1007/s15010-020-01424-5.

Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 2021;42:206. https://doi.org/10.1093/eurheartj/ehaa190.

Kow CS, Hasan SS. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection 2020;48:805-806. https://doi.org/10.1007/s15010-020-01441-4.

Li Y, Na L, Lü Z, Jiang Z. Regeneration of sulfur poisoned La0.75Sr0.25Cr0.5Mn0.5O3-δ anode of solid oxide fuel cell using electrochemical oxidative method. Electrochim Acta 2019;304:342-349. https://doi.org/10.1016/j.electacta.2019.03.027.

RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:1637-1645. https://doi.org/10.1016/s0140-6736(21)00676-0.

Alter P, Grimm W, Herzum M, Ritter M, Rupp H, Maisch B. [Physical activity and sports in heart failure due to myocarditis and dilated cardiomyopathy]. Herz 2004;29:391-400. https://doi.org/10.1007/s00059-004-2579-z.

Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction (Abingdon, England) 2019;114:1670-1678. https://doi.org/10.1111/add.14703.

Cómo citar
1.
Forero-Saldarriaga S, Puerta-Rojas JD, Estupiñán-Paredes RN, Coy-Pedraza LC, Moreno-Ruiz NL, Castellanos-Parada J. Infección por SARS-CoV-2 y miocarditis. Med. Lab. [Internet]. 11 de enero de 2022 [citado 28 de junio de 2022];26(1):35-6. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/558
Publicado
2022-01-11
Sección
Artículos de revisión
Crossref Cited-by logo

Más sobre este tema

Artículos más leídos del mismo autor/a